[ORGANIZATION]
depemokimab
Featured in 1 tracked story · first seen
Situations
Depemokimab approval and clinical use in Europe
2 clusters · 21 sources · last updated
Latest: European Commission approves depemokimab for severe asthma
Medical experts initially highlighted the efficacy of depemokimab, a monoclonal antibody targeting interleukin 5 (IL-5), for treating severe eosinophilic asthma and nasal polyposis. During the European Respiratory Societ